DINESH

Bhagiradha Chemicals

Latest CMP 239
Today's Change ▼ -0.71%
52-Week High / Low 301 | 171
Price Date: 30-Sep-2026
Recommendation Buy
Target Price 302
Expected Upside 12.4%
Forecast Horizon 2 Years
Historical CAGR Not Available
1,000 Invested —
Today's Value —
Investment Period < 5 Years

Stock Snapshot

Post Results Return
-3.2%
Mild Negative Re-rating
1-Year Target Price
278
2-Year Target Price
302
52-Week High / Low
301 / 171
20-Day Return
-11.0%
Market Cap (Cr.)
3,101
Current PE
112.8
P/BV Ratio
4.4
Dividend Yield
0.1%
Industry PE
15.4

Price Performance

Vista Outlook

Basis of our Recommendation

Bhagiradha Chemicals is navigating a transformative phase, with management emphasizing a strategic pivot towards high-value agrochemical products and significant capital investments in its Bheema Fine Chemicals subsidiary. The company's recent performance has been bolstered by improved realizations and successful new product launches, which are expected to drive revenue growth beyond historical levels. Vista's financial outlook reflects this optimism, forecasting accelerating revenue growth and improving margins as the company capitalizes on its backward integration strategy and operational efficiencies. However, potential headwinds from crude-linked raw material price volatility and geopolitical tensions could impact profitability. Over the next 12-24 months, Bhagiradha's focus on diversifying its product portfolio and enhancing manufacturing capabilities positions it well for long-term growth, despite the challenges posed by external market conditions. Key opportunities include the successful ramp-up of the new facility and deepening customer relationships, while watchpoints include the execution risks associated with scaling operations and the impact of rising raw material costs on margins

👍 Why We Like This Stock

  • Management's focus on high-value product development and backward integration is expected to enhance margins and reduce dependency on imports
  • The successful launch of new products and expansion of manufacturing capacity are likely to drive revenue growth beyond historical levels
  • Stable demand for agricultural inputs and improving pricing power in the industry provide a favorable backdrop for Bhagiradha's growth trajectory

⚠ Things To Watch Out For

  • Geopolitical tensions and rising crude oil prices pose risks to raw material costs and overall profitability
  • Execution risks associated with the ramp-up of the new manufacturing facility could impact short-term performance
  • Potential margin compression from increased depreciation and finance costs related to capital expenditures may moderate profitability in the near term

Key Parameters

Balance Sheet Strength
Stable Financial Structure
Market Share
Stable
Industry Outlook
Improving
Analyst View
Not Available
Dividend History
Consistent
FII Holdings
Stable

Financial Snapshot

View Technicals Analysis →
Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 408 440 536 675 785
Profit Before Tax (Cr.) 27 25 21 36 39
PBT Margin 6.6% 5.7% 3.9% 5.3% 5.0%
Net Profit (Cr.) 20 16 17 29 32
Earnings Per Share 1.6 1.2 1.3 2.2 2.4

Analyst Recommendations

No analyst recommendations available.

Consensus Recommendation ► None
Consensus Target —
Coverage 0 Analysts
Analysts' Viewpoint

Company Overview

Show Company Profile

Bhagiradha Chemicals & Industries Limited manufactures and sells crop protection chemicals in India, rest of Asia, and Europe. The company offers insecticides, such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran, thiamethoxam, imidacloprid, pymetrozine, and chlorantraniliprole; fungicides, including azoxystrobin and trifloxystrobin; herbicides comprising triclopyr, cloquintocet-mexyl, clodinafop-propargyl, sulfosulfuron, and pinoxaden; and specialty intermediates consisting of 2,6-dichloroaniline and 2-ethylsulfonylimidazo pyridine-3-sulfonamide. It serves agrochemical manufacturers and pesticide formulators and traders. The company was incorporated in 1993 and is headquartered in Hyderabad, India.